| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 95819 |
|
10,780 |
10,722 |
$2.45M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
38,328 |
37,093 |
$2.40M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
2,531 |
2,354 |
$2.02M |
| 95886 |
|
13,288 |
12,670 |
$1.40M |
| 95911 |
|
8,982 |
8,892 |
$1.09M |
| 95912 |
|
4,259 |
4,176 |
$600K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,992 |
5,987 |
$576K |
| 64405 |
|
13,215 |
12,471 |
$504K |
| 64450 |
|
12,564 |
10,281 |
$489K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,447 |
10,211 |
$419K |
| 92546 |
|
4,347 |
4,343 |
$294K |
| 92540 |
|
4,343 |
4,339 |
$267K |
| 20553 |
|
14,119 |
13,738 |
$263K |
| 99215 |
Prolong outpt/office vis |
3,317 |
3,164 |
$263K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
5,619 |
1,475 |
$230K |
| 76942 |
|
8,589 |
8,540 |
$220K |
| 93880 |
|
1,774 |
1,774 |
$205K |
| 64615 |
|
1,873 |
1,870 |
$119K |
| 99223 |
Prolong inpt eval add15 m |
968 |
944 |
$108K |
| 99233 |
Prolong inpt eval add15 m |
1,762 |
671 |
$101K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
15,786 |
15,669 |
$100K |
| 92537 |
|
4,238 |
4,235 |
$99K |
| 99442 |
|
1,597 |
1,527 |
$76K |
| 95874 |
|
2,338 |
2,329 |
$73K |
| 99406 |
|
9,501 |
9,237 |
$70K |
| 99441 |
|
2,953 |
2,809 |
$63K |
| 99245 |
|
526 |
520 |
$62K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,433 |
6,110 |
$58K |
| 99205 |
Prolong outpt/office vis |
486 |
483 |
$57K |
| 99222 |
Initial hospital care, per day, moderate complexity |
547 |
535 |
$43K |
| 20605 |
|
1,767 |
1,740 |
$39K |
| 99220 |
|
303 |
297 |
$30K |
| 20606 |
|
480 |
475 |
$27K |
| 92547 |
|
4,345 |
4,339 |
$23K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
169 |
169 |
$19K |
| 92653 |
|
217 |
217 |
$11K |
| 95930 |
|
203 |
203 |
$8K |
| 99219 |
|
80 |
79 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
70 |
70 |
$4K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,534 |
2,329 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,139 |
4,038 |
$4K |
| 99415 |
Prolong outpt/office vis |
845 |
828 |
$4K |
| 99407 |
|
177 |
175 |
$3K |
| G0407 |
Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth |
122 |
39 |
$3K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
13 |
13 |
$1K |
| G0426 |
Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth |
22 |
21 |
$1K |
| 96127 |
|
263 |
263 |
$657.80 |
| 20552 |
|
34 |
34 |
$513.15 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,197 |
1,167 |
$374.54 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
43,392 |
41,817 |
$2.83 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
16,629 |
16,186 |
$2.53 |
| 4004F |
|
12,535 |
12,139 |
$2.38 |
| 1036F |
|
30,655 |
29,639 |
$0.45 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
20,024 |
19,395 |
$0.30 |
| G3002 |
Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.) |
32 |
32 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
547 |
535 |
$0.00 |
| M1030 |
Patients with clinical indications for imaging of the head |
90 |
89 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
4,638 |
4,522 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
1,700 |
1,690 |
$0.00 |
| G9634 |
Health-related quality of life assessed with tool during at least two visits and quality of life score remained the same or improved |
43 |
40 |
$0.00 |
| 0001U |
|
41 |
41 |
$0.00 |
| M1008 |
<50% of total number of a patient's outpatient ra encounters assessed |
34 |
33 |
$0.00 |